MedPath

EXBLIFEP 2 G/0,5 G POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION

EXBLIFEP 2 G/0,5 G POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION

Commercialized
Register Number

1241794001

Prescription Type

Uso Hospitalario

Authorization Date

Apr 4, 2024

Dosage Form

POLVO PARA CONCENTRADO PARA SOLUCIÓN PARA PERFUSIÓN

Route: VÍA INTRAVENOSA

Product Details

Detailed information about this CIMA AEMPS approved pharmaceutical product.

Basic Information

Key regulatory and product classification details

Regulatory Details

Register Number1241794001
EMA Approved
Yes

Drug Classification

Generic
No
Orphan
No
Biosimilar
No
Commercialized
Yes
CIMA AEMPS Classification

INGREDIENTS (2)

CEFEPIMA DIHIDROCLORURO MONOHIDRATOActive
Quantity: 2378 mg
Name: CEFEPIMA DIHIDROCLORURO MONOHIDRATO
ENMETAZOBACTAMActive
Quantity: 500 mg
Name: ENMETAZOBACTAM

ATC CLASSIFICATION (3)

J01D
J01DE
J01DE51

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.